“`html
Hims & Hers Health Inc (Symbol: HIMS) shares recently traded at $15.51, surpassing the average 12-month analyst target price of $15.18. This shift raises questions regarding potential analyst reactions, which could involve downgrading valuations or adjusting target prices higher due to favorable business developments.
The average target is based on contributions from 12 analysts, with forecasts ranging from $11.00 to $18.00 and a standard deviation of $2.098. Currently, there are 6 strong buy ratings, 1 buy rating, 5 hold ratings, and no sell ratings, resulting in an average rating of 1.92, where 1 is a strong buy and 5 is a strong sell.
“`
